Results 91 to 100 of about 8,070,517 (356)
National Drugs Advisory Board annual report and accounts, 1994
, 1994 The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No. 163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core
Reports of side effects associated with the use of drugs 1985 [PDF]
, 1985 Halothane In the ten year period of 1970 to 1980 the Board received 9 reports of hepatitis (2 fatal) associated with the repeated use of halothane. This mirrors experience in other countries.
National Drugs Advisory Board (NDAB)
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga +3 more
wiley +1 more source
BiologyPhaeodactylum tricornutum is rich in bioactive substances, rendering it valuable in nutrition and medicine. Epigenetic editing mediated by human RNA demethylase FTO can significantly increase the yields of rice and potato and offers significant potential
Yanan Yang +4 more
doaj +1 more source
Reports of side effects associated with the use of drugs 1976
, 1977 The National Drugs Advisory Board received 463 reports in all during 1976. From these 844 adverse reactions were recorded associated with the use of drugs during the year. There were 13 cases of drug interactions - these are listed separately.
National Drugs Advisory Board (NDAB)
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine +21 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak +9 more
wiley +1 more source
Recent Advances in Anti-Inflammatory Compounds from Marine Microorganisms
Marine DrugsMarine microbial secondary metabolites with diversified structures have been found as promising sources of anti-inflammatory lead compounds. This review summarizes the sources, chemical structures, and pharmacological properties of anti-inflammatory ...
Guihua Yang +9 more
doaj +1 more source
National Drugs Advisory Board annual report 1975
, 1975 By the end of 1975. the National Drugs Advisory Board had 15 months of experience in the management of mandatory licensing systems for medicinal products and for manufacturers of pharmaceuticals in Ireland. With few exceptions.
National Drugs Advisory Board (NDAB)
core
Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs [PDF]
, 2012 13.1 Drugs for cardiac arrhythmias\ud 13.1.1 Introduction to cardiac arrhythmias\ud 13.1.2 Cardiac action potentials\ud 13.1.3 Mechanisms of cardiac arrhythmias\ud 13.1.3 Class I\ud 13.1.4 Class II\ud 13.1.5 Class III\ud 12.1.6 Class IV\ud 13.1.7 ...
Doggrell, Sheila
core